KJERSTI TAYLOR: Open Payments
NPI 1588301675 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$189 in 10 payments from 7 companies in 2025. Trend: 2023 $714 · 2024 $866 · 2025 $189
Food & beverage: $189
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 2 | $40 |
| Exact Sciences Corporation | 2 | $35 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $32 |
| Lilly USA, LLC | 1 | $25 |
| SHIELD THERAPEUTICS INC | 1 | $24 |
| Neos Therapeutics, LP | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $15 |
Products named: Cologuard Collection Kit, XIFAXAN, MOUNJARO, ACCRUFER, Adzenys XR-ODT, NEXLETOL.
Industry payments across TX — which companies pay providers there.
